SCHEMBL220664

SCHEMBL220664

COc1[c]ccc(C)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29088190 0.92 ACHE (0.34)
SCHEMBL7479452 0.85 ACHE (0.41)
SCHEMBL9180621 0.78 ACHE (0.42)
SCHEMBL4858324 0.78 CYP3A4 (0.33)
SCHEMBL11466692 0.77 MCL1 (0.37)
SCHEMBL7997628 0.77 PTPN1 (0.35)
SCHEMBL77754 0.76 CA1 (0.39)
SCHEMBL11124920 0.76
SCHEMBL11513183 0.76 NQO1 (0.36)
SCHEMBL158136 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1085 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118290239-A Nickel-catalyzed method for 1, 3-conjugated diene number 3 selective Heck reaction 中国科学院大连化学物理研究所 2024-07-05 CN claimed
CN-118234704-A Method for producing alkyl acrylate dimer 法国特种经营公司 2024-06-21 CN claimed
CN-118159546-A Bis-aminophosphines as catalysts for dimerization of alkyl acrylates 法国特种经营公司 2024-06-07 CN claimed
US-11987588-B2 Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related thereto ARENA PHARMACEUTICALS, INC. (US) 2024-05-21 US claimed
EP-4304585-A2 METHYL-SUBSTITUTED PYRIDINE AND PYRIDAZINE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE Latigo Biotherapeutics, Inc. (US) 2024-01-17 EP claimed
CN-117062607-A Methyl substituted pyridine and pyridazine compounds, derivatives thereof and methods of use thereof 拉堤果生物医疗股份有限公司 2023-11-14 CN claimed
US-20230339904-A1 ISOINDOLINONES, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS BIOTHERYX, INC. 2023-10-26 US claimed
EP-3720858-B1 MODULATORS OF THE BETA-3 ADRENERGIC RECEPTOR USEFUL FOR THE TREATMENT OR PREVENTION OF HEART FAILURE AND DISORDERS RELATED THERETO ARENA PHARM INC (US) 2023-06-07 EP claimed
WO-2023066844-A1 BIS-AMINOPHOSPHINES AS CATALYSTS FOR THE DIMERIZATION OF ALKYL ACRYLATES RHODIA OPERATIONS (FR) 2023-04-27 WO claimed
WO-2023066829-A1 PROCESSES FOR PRODUCING ALKYL ACRYLATE DIMERS RHODIA OPERATIONS (FR) 2023-04-27 WO claimed
US-RE37344-E1 FOR FORMING COMPLEXES WITH IRIDIUM OR RHODIUM WHICH ARE USED FOR ENANTIOSELECTIVE HYDROGENATION CATALYSTS FOR HOMOGENEOUS HYDROGENATION OF PROCHIRAL UNSATURATED COMPOUNDS NOVARTIS CORPORATION 2001-08-28 US claimed
WO-2000078733-A1 PHENOXY FLUOROPYRIMIDINES BAYER AKTIENGESELLSCHAFT (DE) 2000-12-28 WO claimed
US-5834080-A Controllably conductive polymer compositions for development systems XEROX CORPORATION (US) 1998-11-10 US claimed
US-5795905-A 3-AMINO-5-PHENYL-1,2,4-TRIAZOLES NEUROCRINE BIOSCIENCES, INC. (US) 1998-08-18 US claimed
EP-0846108-A1 AMINO-SUBSTITUTED THIADIAZOLES, PYRIMIDINES, TRIAZINES OR TRIAZOLES USEFUL AS CTF RECEPTOR ANTAGONISTS NEUROCRINE BIOSCIENCES, INC. (US) 1998-06-10 EP claimed
WO-1996039400-A1 AMINO-SUBSTITUTED THIADIAZOLES, PYRIMIDINES, TRIAZINES OR TRIAZOLES USEFUL AS CTF RECEPTOR ANTAGONISTS NEUROCRINE BIOSCIENCES, INC. (US) 1996-12-12 WO claimed
US-5583241-A FORM COMPLEXES WITH RHODIUM OR IRIDIUM USED FOR HYDROGENATION CATALYSTS CIBA-GEIGY CORPORATION (US) 1996-12-10 US claimed
US-5466844-A Ferrocene diphosphines as ligands for homogeneous catalysts CIBA-GEIGY CORPORATION (US) 1995-11-14 US claimed
US-5463097-A Ferrocenyl diphosphines as ligands for homogeneous catalysts CIBA-GEIGY CORPORATION (US) 1995-10-31 US claimed
US-5371256-A With rhodium and iridium CIBA-GEIGY CORPORATION (US) 1994-12-06 US claimed